Brincidofovir is a robust replication inhibitor against African swine fever virus in vivo and in vitro

Brincidofovir is a robust replication inhibitor against African swine fever virus in vivo and in vitro

African swine fever virus (ASFV) infection is a major public and socioeconomic concern that has a serious impact on the global swine industry. Unfortunately, there are currently no commercially available vaccines or antiviral agents that are both safe and effective against ASFV. In the study, we use...

Full description

Bibliographic Details
Main Authors: Shibang Guo, Yibo Zhang, Zhankui Liu, Daozhong Wang, Hui Liu, Liang Li, Qichao Chen, Dan Yang, Qingyun Liu, Huihui Guo, Shuang Mou, Huanchun Chen, Xiangru Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Emerging Microbes and Infections
Subjects:
African swine fever virus
kinase inhibitor library
antiviral activity
brincidofovir
Chinese Bama minipig
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2023.2220572

Similar Items

Similar Items